Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The decreased expression of beta(2)-adrenergic receptors (beta(2)-R) on lymphatic cells in rheumatic diseases like RA, together with an impaired influence of catecholamines on immune function in these patients, further underlines the concept of a dysfunction of the ANS in rheumatic diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP663501.RAYcZ_8rQ1x8pL53PasU9NGLddMsLz1ooRAluAr2EkLw0130_assertion description "[The decreased expression of beta(2)-adrenergic receptors (beta(2)-R) on lymphatic cells in rheumatic diseases like RA, together with an impaired influence of catecholamines on immune function in these patients, further underlines the concept of a dysfunction of the ANS in rheumatic diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP663501.RAYcZ_8rQ1x8pL53PasU9NGLddMsLz1ooRAluAr2EkLw0130_provenance.
• NP938445.RAroP2w73yVCXiFKuThhxsWQVfAjH0NiX_zG1weR2IdGM130_assertion description "[The decreased expression of beta(2)-adrenergic receptors (beta(2)-R) on lymphatic cells in rheumatic diseases like RA, together with an impaired influence of catecholamines on immune function in these patients, further underlines the concept of a dysfunction of the ANS in rheumatic diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP938445.RAroP2w73yVCXiFKuThhxsWQVfAjH0NiX_zG1weR2IdGM130_provenance.
• NP375417.RARHpeB72U7a3vY1IswoSQGFbpm5i43iTbC7mjMdfYiG4130_assertion description "[The decreased expression of beta(2)-adrenergic receptors (beta(2)-R) on lymphatic cells in rheumatic diseases like RA, together with an impaired influence of catecholamines on immune function in these patients, further underlines the concept of a dysfunction of the ANS in rheumatic diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375417.RARHpeB72U7a3vY1IswoSQGFbpm5i43iTbC7mjMdfYiG4130_provenance.
• NP749217.RAlxEOQglk3mK6-W_HlIKFG29Kax-H-g0_CyvFoIp0yhU130_assertion description "[The decreased expression of beta(2)-adrenergic receptors (beta(2)-R) on lymphatic cells in rheumatic diseases like RA, together with an impaired influence of catecholamines on immune function in these patients, further underlines the concept of a dysfunction of the ANS in rheumatic diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP749217.RAlxEOQglk3mK6-W_HlIKFG29Kax-H-g0_CyvFoIp0yhU130_provenance.
• NP842038.RAZIck17VkfNXKATdD_YIm4VhNp707HWZz7RmWQ30QY1g130_assertion description "[The decreased expression of beta(2)-adrenergic receptors (beta(2)-R) on lymphatic cells in rheumatic diseases like RA, together with an impaired influence of catecholamines on immune function in these patients, further underlines the concept of a dysfunction of the ANS in rheumatic diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842038.RAZIck17VkfNXKATdD_YIm4VhNp707HWZz7RmWQ30QY1g130_provenance.
• NP360660.RAZxP_KthBZqDJibsOcQ2ugacX3PsBqAif9qmGAu4Ce9c130_assertion description "[The decreased expression of beta(2)-adrenergic receptors (beta(2)-R) on lymphatic cells in rheumatic diseases like RA, together with an impaired influence of catecholamines on immune function in these patients, further underlines the concept of a dysfunction of the ANS in rheumatic diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP360660.RAZxP_KthBZqDJibsOcQ2ugacX3PsBqAif9qmGAu4Ce9c130_provenance.
• NP360661.RAcUhQqJaB6G45H3LEl9Q_zsxVDq9ZM5k1o06nYijfp8k130_assertion description "[The decreased expression of beta(2)-adrenergic receptors (beta(2)-R) on lymphatic cells in rheumatic diseases like RA, together with an impaired influence of catecholamines on immune function in these patients, further underlines the concept of a dysfunction of the ANS in rheumatic diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP360661.RAcUhQqJaB6G45H3LEl9Q_zsxVDq9ZM5k1o06nYijfp8k130_provenance.
• NP360658.RAhjRns0KjH1HCKMkkMtV3SBxPRqB_ReL9vkdvVLY5Erk130_assertion description "[The decreased expression of beta(2)-adrenergic receptors (beta(2)-R) on lymphatic cells in rheumatic diseases like RA, together with an impaired influence of catecholamines on immune function in these patients, further underlines the concept of a dysfunction of the ANS in rheumatic diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP360658.RAhjRns0KjH1HCKMkkMtV3SBxPRqB_ReL9vkdvVLY5Erk130_provenance.
• NP587791.RArUIc9OINpJ3c_6aKCLZufo2j9c88j4edROKc_1xvzlw130_assertion description "[The decreased expression of beta(2)-adrenergic receptors (beta(2)-R) on lymphatic cells in rheumatic diseases like RA, together with an impaired influence of catecholamines on immune function in these patients, further underlines the concept of a dysfunction of the ANS in rheumatic diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP587791.RArUIc9OINpJ3c_6aKCLZufo2j9c88j4edROKc_1xvzlw130_provenance.
• NP841894.RAnFkzTbejjEQIE2QuTOKECCjAt21A9foajr3gLCVIWcY130_assertion description "[The decreased expression of beta(2)-adrenergic receptors (beta(2)-R) on lymphatic cells in rheumatic diseases like RA, together with an impaired influence of catecholamines on immune function in these patients, further underlines the concept of a dysfunction of the ANS in rheumatic diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841894.RAnFkzTbejjEQIE2QuTOKECCjAt21A9foajr3gLCVIWcY130_provenance.
• NP587576.RA3u795S6k1qrIgxU3j6yuPyty151xnsSAEI_P-ldAiiQ130_assertion description "[The decreased expression of beta(2)-adrenergic receptors (beta(2)-R) on lymphatic cells in rheumatic diseases like RA, together with an impaired influence of catecholamines on immune function in these patients, further underlines the concept of a dysfunction of the ANS in rheumatic diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP587576.RA3u795S6k1qrIgxU3j6yuPyty151xnsSAEI_P-ldAiiQ130_provenance.
• NP360659.RA1olUTYtp05nB7ZmgQBoUXXwnFENkKbgmge37IYlqNuM130_assertion description "[The decreased expression of beta(2)-adrenergic receptors (beta(2)-R) on lymphatic cells in rheumatic diseases like RA, together with an impaired influence of catecholamines on immune function in these patients, further underlines the concept of a dysfunction of the ANS in rheumatic diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP360659.RA1olUTYtp05nB7ZmgQBoUXXwnFENkKbgmge37IYlqNuM130_provenance.